Awareness of personalised medicine in cancer patients

Dr Sabine Tejpar - University Hospital Gasthuisberg, Lueven, Belgium
Awareness of personalised medicine in cancer patients ( Dr Sabine Tejpar - University Hospital Gasthuisberg, Lueven, Belgium )
30 Sep 2012

Phase I and II trials focus on drug combination slowing development of resistance inhibiting BRAF

Prof Yossef Yarden - Weizmann Institute of Science, Israel.
Phase I and II trials focus on drug combination slowing development of resistance inhibiting BRAF ( Prof Yossef Yarden - Weizmann Institute of Science, Israel. )
29 Sep 2012

Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib

Dr Tony Mok - Chinese University of Hong Kong
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib ( Dr Tony Mok - Chinese University of Hong Kong )
29 Sep 2012

Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III MISSION trial

Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III MISSION trial ( Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain )
29 Sep 2012

Highlights from the 17th International Conference on Cancer Nursing

Greta Cummings – President of the International Society of Nurses of Cancer Care
Highlights from the 17th International Conference on Cancer Nursing ( Greta Cummings – President of the International Society of Nurses of Cancer Care )
21 Sep 2012

Educational programmes for oncology nurses

Prof Mary Jane Esplen – University Health Network, Toronto, Canada
Educational programmes for oncology nurses ( Prof Mary Jane Esplen – University Health Network, Toronto, Canada )
21 Sep 2012

Oncology nursing and survivorship

Catherine Glennon – The University of Kansas Cancer Center, USA
Oncology nursing and survivorship ( Catherine Glennon – The University of Kansas Cancer Center, USA )
21 Sep 2012

Smoking cessation in the Czech Republic

Linda Sarna – University of California Los Angeles, USA
Smoking cessation in the Czech Republic ( Linda Sarna – University of California Los Angeles, USA )
20 Sep 2012

Best practice in nurse-led chemotherapy, standardising services, as well as electronic prescriptions and nurse-physician communication

Elaine Lennan – University Hospital Southampton NHS Foundation Trust, UK
Best practice in nurse-led chemotherapy, standardising services, as well as electronic prescriptions and nurse-physician communication ( Elaine Lennan – University Hospital Southampton NHS Foundation Trust, UK )
20 Sep 2012

Cost effective care and the state of oncology in India

Dr Rajendra Badwe – Tata Memorial Hospital, Mumbai, India
Cost effective care and the state of oncology in India ( Dr Rajendra Badwe – Tata Memorial Hospital, Mumbai, India )
23 Jul 2012

Highlights from the 2012 NCID Meeting

Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Highlights from the 2012 NCID Meeting ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
23 Jul 2012

Cancer care in Cameroon and treatment options

Dr Paul Ndom – Taounde University, Cameroon
Cancer care in Cameroon and treatment options ( Dr Paul Ndom – Taounde University, Cameroon )
23 Jul 2012